Source: Eur Respir J 2010; 35: 247-265
Disease area: Paediatric lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Smyth A. R., Barbato A., Beydon N., Bisgaard H., de Boeck K., Brand P., Bush A., Fauroux B., de Jongste J., Korppi M., O'Callaghan C., Pijnenburg M., Ratjen F., Southern K., Spencer D., Thomson A., Vyas H., Warris A., Merkus P. J.. Respiratory medicines for children: current evidence, unlicensed use and research priorities. Eur Respir J 2010; 35: 247-265

Member's Comments

No comment yet.

Related content which might interest you: Re-certification of respiratory professionals: current practice and the future – educational forum report Source: Breathe, 13 (2) 77; 10.1183/20734735.001817 Year: 2017 The effect of respiratory comorbidities on the provision of cessation assistance in six EU countries: are clinicians doing enough? Source: International Congress 2018 – EUREST-PLUS: implementation of the tobacco control policy to reduce lung disease Year: 2018 Introduction of characteristics of evidence-based practice Source: Annual Congress 2005 - Workshop: evidence-based practice: an approach to care Year: 2005 Advocacy in respiratory medicine: European medicines agency Source: ERS Summit on priorities in respiratory medicine 2011 Year: 2011 A survey of specialist opinions on biomarker use in severe asthma in Australia: scepticism but hope? Source: ERJ Open Res, 6 (2) 00113-2020; 10.1183/23120541.00113-2020 Year: 2020 Assessment methods in respiratory medicine training in Europe: current status and future needs Source: Breathe, 16 (1) 190314; 10.1183/20734735.0314-2019 Year: 2020 How to apply evidence based practice critique method to review of guidelines Source: Annual Congress 2005 - Workshop: evidence-based practice: an approach to care Year: 2005 Helping consumers find high-quality health information on the www: impact of online health information on clinical practice Source: Annual Congress 2006 - Web-based patient education Year: 2006 Unlicensed and off-label prescription of respiratory drugs to children Source: Eur Respir J 2004; 23: 310-313 Year: 2004 COPD admissions and inhaled medications: Escalating prescription costs but no evidence of effect. A national primary care study Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care Year: 2013 mHealth systems for asthma self-management: Opinions of people with asthma and healthcare professionals (HCPs) on their use and functions Source: International Congress 2016 – Abstracts in medical education, the web and the internet Year: 2016 International research outputs and funding in respiratory medicine Source: Eur Respir J 2003; 22: Suppl. 45, 484s Year: 2003 Preventing skin care issues associated with face masks used for domiciliary non-invasive ventilation: what do users and their carers think are the most relevant future research questions? Source: International Congress 2019 – Treatment of chronic respiratory failure with noninvasive ventilation Year: 2019 Evidence-based medicines for children: ethical aspects Source: Eur Respir J 2007; 29: 821-822 Year: 2007 ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions Source: Guideline 2019 Year: 2019 Impact of asthma management guidelines on the prescribing practices of Asian physicians Source: Eur Respir J 2003; 22: Suppl. 45, 356s Year: 2003 Future of eHealth in TB management: perspectives of patients and medical staff Source: Virtual Congress 2021 – Digital innovations in tuberculosis and implementation research in the era of COVID-19: collaborative activities between the WHO and ERS Year: 2021 “I don’t think there’s a simple way of doing it:” the use of an electronic alert to identify excessive prescribing of short-acting beta2-agonists for people with asthma – a qualitative study with asthma experts and primary care staff Source: Virtual Congress 2020 – Diagnosis and management of airways disease in primary care Year: 2020 How do the new guidelines work? Practical approach to the new guidelines for asthma diagnosis in children, discussion and Q&A Source: Virtual Congress 2021 – The ERS guidelines for the diagnosis of asthma in children aged 5-16 years Year: 2021 The impact of national recommendations on antibiotic treatment of community acquired pneumonia. Do pediatricians follow the national guidelines? Source: International Congress 2017 – Pulmonary infection and inflammation Year: 2017